With over 20 years of combined experience in biomedical research, we bring a deep expertise in drug discovery, target validation, and data science. Our work spans across multiple therapeutic areas, leveraging cutting-edge techniques in CRISPR, functional genomics, and AI-driven synthetic biology.
Meet the team
Paloma Guzzardo Tamargo, PhD
Co-founder
Paloma has worked in biotech and pharma for over ten years specializing in target validation, drug discovery and genome engineering. She was the founding member of the R&D team at Seattle-based start-up Variant Bio which uses human genetic, transcriptomic and metabolomic data to discover novel drug targets. As Director of Target Biology, she led several of the drug discovery programs spanning diverse therapeutic areas and drug modalities. Prior to Variant Bio, she was part of the Regeneron Genetics Center where she managed cross-functional projects to ensure dissemination and tracking of novel genetically-backed targets. Additionally, she led a team at Horizon Genomics in Vienna, Austria that delivered CRISPR genome edited cells to customers and led technology development efforts. Paloma received a BS from the University of Puerto Rico and a PhD in Biology from the Cold Spring Harbor Laboratory School of Biological Sciences, where she trained with Dr. Greg Hannon.